Protéolyse du facteur von Willebrand et cardiopathies à forces de cisaillement élevées: nouvelles approches diagnostiques et thérapeutiques Dans la première partie de ce travail, nous mettons en évidence l’intérêt d’une immunothérapie spécifique à base d’anticorps monoclonal pour la prévention de la dégradation du facteur von Willebrand (VWF) sous assistance circulatoire mécanique à flux continu. Via un anticorps monoclonal murin ciblant le domaine D4 du VWF et inhibant partiellement l’interaction VWF-ADAMTS13, une inhibition partielle de la dégradation du VWF est observée sur sang total dans un modèle ex-vivo d’assistance circulatoire mécanique.Dans la seconde partie, nous avons étudié l’influence de soudaines variations de l’intensité des forces de cisaillement sur la multimérisation du VWF dans 3 modèles in-vivo: un modèle lapin de sténose de l’aorte ascendante, à l’initiation d’une assistance ventriculaire gauche par une pompe à flux continu chez des patients en insuffisance cardiaque terminale et lors d’un remplacement valvulaire aortique par voie percutané chez des patients avec un rétrécissement aortique sévère. Les variations observées du profil multimérique sont très dynamiques survenant quelques minutes après les modifications des conditions de flux. Notre étude met ainsi en évidence une nouvelle application potentielle du VWF comme biomarqueur d’anomalies de flux dans les cardiopathies à forces de cisaillement élevées. Un monitoring en temps réel du VWF pourrait notamment avoir un intérêt en cardiologie interventionnelle pour les techniques percutanées utilisées pour le traitement du rétrécissement aortique.La dernière partie de ce travail porte sur le développement d’un test ELISA pour le diagnostic des formes acquises ou constitutionnelles de maladie de Willebrand secondaire à une protéolyse excessive du VWF par l’ADAMTS13. Ce test pourrait constituer une alternative intéressante aux actuelles méthodes électrophorétiques pour le diagnostic et la prise en charge de ces pathologies hémorragiques. / In the first part of the thesis, we describe a novel approach based on antibody-based therapy to prevent the acquired von Willebrand factor (VWF) degradation observed in continuous-flow mechanical circulatory assist device therapy. Via a murine monoclonal antibody directed against VWF D4 domain and thus interfering with VWF-ADAMTS13 binding, a partial inhibition of VWF degradation is observed in whole blood using an ex vivo circulatory assist device model. In the second part of the thesis, we investigated the relationship between acute changes in shear stress and variations in VWF multimeric profile in three distincts models in vivo: in a rabbit aortic banding model, in end-stage heart failure patients at initiation of continuous-flow ventricular assist device therapy and in severe aortic stenosis patients undergoing percutaneous aortic valve procedures. Variations in VWF multimeric profile in those settings are highly dynamic occuring within minutes after changes in shear stress status. Our study highlights that VWF could be used as a biomarker of blood flow in high shear cardiovascular disorders. A bedside VWF-monitoring could be of clinical interest in interventional cardiology for percutaneous aortic valve procedures used in severe aortic stenosis.The last part of the thesis focused on the development of an ELISA-based diagnosis of constitutive or acquired VWF disorders associated with an increased ADAMTS13-mediated VWF proteolysis. Such assay might represent an attractive alternative to electrophoresis-based assays in the diagnosis and management of such bleeding disorders.

In this thesis, we propose a Serious Game (SG) for children with the Autism Spectrum Disorder (ASD) that builds on the concept of LEGO®-Based Therapy that is aimed at improving social and cognitive skills. The proposed SG is composed of building blocks augmented with electronic modules that connect to a computing device that provides visual feedback. We investigate the effects of using the proposed computer SG by comparing it to a non-computer block-game during two empirical studies, one following an unstructured play approach and a second one with structured play by assigning roles to the players. For the first study, the proposed system showed an improvement in social interaction, collaborative play and exercise performance, as well as a decrease in solitary play. For the second study, the proposed system showed an improvement in social interaction, positive vocalizations and exploratory behavior. There was also a marked preference towards the proposed game. Furthermore, we perceived a decrease on the assistance needed when using the proposed system during both studies. Our results suggest that the proposed system can be a useful play therapy tool aimed for young children with ASD.

京都大学 / 0048 / 新制・課程博士 / 博士(医学) / 甲第19561号 / 医博第4068号 / 新制||医||1013(附属図書館) / 32597 / 京都大学大学院医学研究科医学専攻 / (主査)教授 吉村 長久, 教授 戸口田 淳也, 教授 高橋 淳 / 学位規則第4条第1項該当 / Doctor of Medical Science / Kyoto University / DFAM

L’approche cognitive du trouble obsessionnel-compulsif (TOC) propose un lien bidirectionnel entre les émotions et les cognitions. Cependant, même si des études montrent une association entre les émotions et le TOC, aucune étude ne s’est attardée à la relation entre les émotions, les cognitions et les comportements au cours d’une thérapie cognitive. La présente étude a pour but d’examiner la relation entre les processus cognitif, béhavioral et émotionnel au cours d’une thérapie basée sur les inférences (TBI) chez des personnes souffrant du TOC. Plus précisément, nous avons observé comment les émotions et les symptômes du TOC s’influencent et comment ils s’influencent à travers le temps. Les patients ont rempli un journal de bord tout au long du processus thérapeutique, notant (de 0 à 100) des émotions clés, ainsi que les croyances et les comportements ciblés durant la thérapie. Des analyses à mesures répétées ont été utilisées afin de maximiser le potentiel des données longitudinales. Les résultats montrent que l’anxiété, la tristesse et la joie ont des trajectoires similaires aux croyances et aux comportements au cours de la thérapie. Les forces et limites de l’étude sont discutées. Les implications des résultats pour le traitement des émotions et des pensées à différents moments de la thérapie sont aussi discutées. / Cognitive approach of obsessive-compulsive disorder (OCD) has suggested a bidirectional link between emotions and cognitions. Few studies have looked at a link between those two components. Although some studies tend to show a relationship between emotions and OCD, no study has looked into the relationship between emotions, cognitions and behaviours over the course of a cognitive therapy. The present case series examines the relationship between cognitive, behavioural and emotional processes over the course of an inference-based therapy (IBT) in OCD clients. More precisely, we looked at how emotions and OCD symptoms influence each other and how they influence each other over time (through therapy). Clients filled in daily diaries rating key emotions, behaviours and beliefs over the course of treatment. A longitudinal analysis based on an event-based approach was used to maximize the potential of longitudinal data. Results showed that anxiety, sadness and joy share similar trajectories with beliefs and behaviours over the course of therapy. Strengths and limitations of the study are noted. Implications for targeting emotions and thoughts at different stages of therapy are also discussed.

INTRODUÇÃO: Este estudo teve por objetivo investigar o efeito da injeção periuretral de células mononucleares derivadas de músculo estriado esquelético (CMDME) e a incorporação dessas células no esfíncter urinário de ratas, em modelo animal de incontinência urinária. MÉTODOS: As CMDMEs, foram isoladas de músculos dos membros pélvicos de ratos endogâmicos Whistar-Kyoto (WKY), machos. Os músculos foram submetidos à dissociação enzimática, seguida de isolamento das células mononucleares, sem necessidade de cultura e/ou expansão. A deficiência esfincteriana foi criada por uretrolise cirúrgica em 20 ratos endogâmicos WKY, fêmeas. Uma semana após, foi realizada a injeção periuretral de 1 x 106 de células, em 10 ratas (grupo CMDME), e 10 ratas receberam injeção de SF a 0,9% (grupo SF). Dez animais foram submetidos à cirurgia Sham e serviram como controle (grupo SHAM). Quatro semanas após a injeção, os ratos foram sacrificados, e as uretras, removidas. A incorporação das CMDMEs masculinas, na uretra feminina, foi confirmada pela detecção do cromossomo Y, através da hibridização in situ fluorescente. A porção média da uretra de cada animal foi processada para coloração pela hematoxilina-eosina e tricrômio de Masson e também imuno-histoquímica para actina e miosina. Usando software digital (Image Pro Plus 6.0), calcularam-se a proporção músculo/tecido conectivo e a proporção de actina e miosina em cada amostra de uretra, sendo as proporções comparadas entre os grupos. As mudanças morfométricas da uretra de cada animal, de cada grupo, foram avaliadas medindo-se o maior e o menor diâmetro da uretra e a espessura média da parede, utilizando software digital (Image J); áreas fracionais da luz, mucosa e camada muscular da uretra foram estimadas usando o método de contagem de pontos. RESULTADOS: No grupo CMDME, houve espessamento das camadas da musculatura lisa e estriada, e menor depósito de tecido conectivo, em relação aos animais do grupo SF. Uma diminuição da proporção músculo/tecido conectivo foi observada no grupo SF, em comparação ao grupo CMDME, e também em relação ao grupo SHAM (0,51 ± 0,28; 1,62 ± 0,53 e 2,27 ± 1,15, respectivamente, p < 0.001). A proporção de actina estava diminuída no grupo SF, em comparação com o grupo CMDME, e com o grupo SHAM (0,18 ± 0,04; 0,27 ± 0,02 e 0,27 ± 0,03, respectivamente, p < 0,001) sendo também observada esta diminuição na proporção de miosina (0,07 ± 0,01; 14 ± 0,02 e 0,15± 0,03, respectivamente, p < 0,001). Não houve diferença entre os grupos SF, CMDME e SHAM em relação ao diâmetro da uretra, espessura da parede uretral e áreas fracionais da luz, mucosa e parede muscular uretral. CONCLUSÕES: As CMDMEs foram incorporadas na uretra do grupo CMDME. Nestes animais, houve diminuição de tecido conectivo e aumento da quantidade de músculo liso e esquelético. As CMDMEs foram facilmente obtidas, sem necessidade de expansão celular, com pequeno tempo de preparo / INTRODUCTION: This study investigated the effect of periurethral injection of skeletal muscle-derived mononuclear cells (SMDMCs) into the urethral sphincter in an animal model of stress urinary incontinence (SUI). METHODS: SMDMCs were isolated from the hind limb muscles of male Wistar-Kyoto (WKY) isogenic inbred rats. The muscles were enzymatically dissociated, and SMDMCs were directly isolated without the need for culture or expansion. Urinary sphincter deficiency was created by surgical urethrolysis in 20 female WKY rats. One week later, 10 rats received an injection of 1 x 106 cells (SMDMC group) and 10 rats received saline injections (Saline group). In addition, 10 rats were subjected to sham surgery (Sham group). Four weeks later, the rats were euthanized and their urethras harvested. The incorporation of male SMDMC in the female urethras was confirmed by the detection of Ychromosomes by fluorescence in situ hybridization (FISH). In addition, hematoxylin and eosin (H&E) and Masson\'s trichrome staining, as well as immunohistochemistry analyses to actin and myosin were performed. Using digital software (Image Pro Plus 6.0), the muscle to connective tissue, actin and myosin ratios were calculated. A urethral morphological evaluation was conduced by measuring the diameters and mean wall thickness, using Image J software. Fractional areas of the lumen, mucosa and muscular layer were estimated using the point counting method. RESULTS: The SMDMCs were successfully incorporated into the urethra. Less collagen was observed among the muscle fibers and less atrophy was found in the smooth and skeletal muscle layers of the SMDMC group. A significant decrease in the muscle to connective tissue ratio was observed in the Saline group, compared with the SMDMC and Sham groups (0,51 ± 0,28 vs 1,62 ± 0,53 vs 2,27 ± 1,15, respectively; p < 0.001). The proportion of the actin was decreased in the Saline group, in comparison with the SMDMC and Sham groups (0,18 ± 0,04 vs 0,27 ± 0,02 vs 0,27 ± 0,03, respectively; p < 0,001); a decrease was also observed in the proportion of myosin (0,07 ± 0,01 vs 0,14 ± 0,02 vs 0,15± 0,03, respectively; p < 0,001). No significant differences were observed among the groups Sham, Saline and SMDMC in terms of urethral diameter, urethral wall thickness and fractional areas of the lumen, mucosa and muscular layer. CONCLUSIONS: The SMDMCs that were incorporated into the injured urethral sphincter resulted in decreased connective tissue and increased muscle content in the SMDMC group. SMDMCs were easily obtained, without need for cell expansion, and they only required a brief preparation time

Light and optical techniques have made a profound impact on modern medicine both in diagnostics and in therapy. Therapeutic action of light is based on photomechanical, photothermal, photochemical and photobiological interactions, depending on the wavelength, power density, exposure time and optical properties of tissue and cells. Last decade experienced a growing rise of commercial devices for management of hair growth, where all of them are based on low levels of light resulting into photobiological, non-thermal interaction of photons with cells, a process that recently has received an official term ‘photobiomodulation’. However, the design and analysis of the reported clinical studies are highly debated in a wider scientific community. The picture is further complicated by a virtual lack of proof about the exact molecular targets that mediate the physiological response of skin and hair follicles (HF) to low levels of light. The goal of this project was to investigate the expression of light-sensitive receptors in the human HF and to study the impact of UV-free blue light on hair growth ex vivo. The expression of Cryptochromes 1 and 2 (CRY1, 2), Opsin 2 and 3 (OPN2 and OPN3), but not other Opsins 1, 4 and 5 was detected in the distinct compartments of skin and anagen HF. Evaluation of the physiological role of detected light-sensitive receptors on hair growth was performed by the modulation of photoreceptors activity in HF ex vivo model. HFs treated with KL001, a stabilizer of CRY1 protein that lengthens the circadian period, delayed HF anagen-catagen transition; while silencing of CRY1 induced premature catagen development accompanied by reduced cell proliferation. Silencing of CRY1 in the HF outer root sheath (ORS) cells in vitro caused downregulation of ii genes involved in the control of proliferation; including the cyclin dependent kinase 6 (CDK6). OPN3 also had a positive effect on metabolic activity and proliferation of the ORS cells in vitro. OPN3 silencing resulted in the altered expression of genes involved in the control of proliferation and apoptosis. Investigated CRY1, OPN2 and 3 greatly absorb in the blue to green-region of the visible spectrum. This led us to investigate the effect of blue light on HF growth. Daily treatment with blue light (453 nm, 3.2 J/cm2, 16 nm full width half maximum) prolonged anagen phase in HF ex vivo that was associated with sustained proliferation. In addition, blue light (3.2 J/cm2) significantly stimulated proliferation of ORS cells in vitro. This effect was abrogated by silencing of OPN3. To summarize, CRY 1, OPN 2 and OPN 3 are expressed in the distinct compartments of the HF, including HF stem cells. Blue light (453 nm) at low radiant exposure exerts a positive effect on hair growth ex vivo, potentially via interaction with OPN3. The further research should be conducted to decipher interactions between blue light and the investigated receptors in the HFs. In addition, the beneficial effect of blue light at low radiant exposure on hair growth raises a possibility of increasing therapeutic efficacy when combined with topical chemistry used for management of hair growth.

Orientador: Rogerio Martins Amorim / Resumo: Estudos com células estromais mesenquimais multipotentes (MSCs) estão em crescente progresso devido às suas propriedades imunomoduladoras, antiinflamatórias, antiapoptóticas e de regeneração tecidual, tornando essa modalidade de terapia celular promissora no tratamento de diversas doenças. Devido à limitada capacidade regenerativa do sistema nervoso central (CNS), causando sequelas funcionais, as MSCs estão sendo investigadas como uma alternativa terapêutica para condições neurológicas inflamatórias, vasculares, traumáticas e degenerativas em diversas espécies animais. A Mieloencefalite protozoária equina (EPM) causada por ambos os protozoários do filo Apicomplexa, Sarcocystis neurona e Neospora hughesi, permanece como uma importante doença neurológica dos equinos nas Américas, embora a maioria dos casos seja devida à infecção por S. neurona. A aplicação da proteômica com sua gama de ferramentas na clínica de equinos pode contribuir significativamente para o entendimento de processos patológicos e facilitar a descoberta de novos alvos terapêuticos ou marcadores diagnósticos. Neste contexto, os objetivos deste estudo foram avaliar o perfil proteômico do líquido cefalorraquidiano (CSF) antes e após múltiplos transplantes intratecal de MSCs em equinos hígidos e o perfil proteômico do CSF de equinos cronicamente afetados pela EPM. Doze cavalos adultos clinicamente saudáveis foram divididos aleatoriamente em três grupos experimentais: grupo DPBS (DPBS ou control; n = 4) onde a sol... (Resumo completo, clicar acesso eletrônico abaixo) / Abstract: Multipotent mesenchymal stromal cell (MSCs) studies are under increasing progress because of their immunomodulatory, anti-inflammatory, antiapoptotic and tissue regeneration properties, making this modality of cell therapy promising in the treatment of various diseases. Due to the limited regenerative capacity of the central nervous system (CNS), causing functional sequelae, MSCs are being investigated as a therapeutic alternative for inflammatory, vascular, traumatic and degenerative neurological conditions in various animal species. Equine protozoal myeloencephalitis (EPM) caused by both protozoa of the Apicomplexa phylum, Sarcocystis neurona and Neospora hughesi, remains an important neurological disease in horses in the Americas, although most cases are due to S. neurona infection. The application of proteomics with its range of tools in the equine clinic can contribute significantly to the understanding of pathological processes and facilitate the discovery of new therapeutic targets or diagnostic markers. In this context, the objectives of this study were to evaluate the proteomic profiling of cerebrospinal fluid (CSF) before and after multiple intrathecal transplantations of MSCs in healthy horses and the CSF proteomic profiling of horses chronically affected by EPM. Twelve clinically healthy adult horses were randomly divided into three experimental groups: DPBS (DPBS or control; n = 4), in which intrathecal "transplants" with Dulbecco's phosphate buffered saline (DPB... (Complete abstract click electronic access below) / Doutor

L’approche cognitive du trouble obsessionnel-compulsif (TOC) propose un lien bidirectionnel entre les émotions et les cognitions. Cependant, même si des études montrent une association entre les émotions et le TOC, aucune étude ne s’est attardée à la relation entre les émotions, les cognitions et les comportements au cours d’une thérapie cognitive. La présente étude a pour but d’examiner la relation entre les processus cognitif, béhavioral et émotionnel au cours d’une thérapie basée sur les inférences (TBI) chez des personnes souffrant du TOC. Plus précisément, nous avons observé comment les émotions et les symptômes du TOC s’influencent et comment ils s’influencent à travers le temps. Les patients ont rempli un journal de bord tout au long du processus thérapeutique, notant (de 0 à 100) des émotions clés, ainsi que les croyances et les comportements ciblés durant la thérapie. Des analyses à mesures répétées ont été utilisées afin de maximiser le potentiel des données longitudinales. Les résultats montrent que l’anxiété, la tristesse et la joie ont des trajectoires similaires aux croyances et aux comportements au cours de la thérapie. Les forces et limites de l’étude sont discutées. Les implications des résultats pour le traitement des émotions et des pensées à différents moments de la thérapie sont aussi discutées. / Cognitive approach of obsessive-compulsive disorder (OCD) has suggested a bidirectional link between emotions and cognitions. Few studies have looked at a link between those two components. Although some studies tend to show a relationship between emotions and OCD, no study has looked into the relationship between emotions, cognitions and behaviours over the course of a cognitive therapy. The present case series examines the relationship between cognitive, behavioural and emotional processes over the course of an inference-based therapy (IBT) in OCD clients. More precisely, we looked at how emotions and OCD symptoms influence each other and how they influence each other over time (through therapy). Clients filled in daily diaries rating key emotions, behaviours and beliefs over the course of treatment. A longitudinal analysis based on an event-based approach was used to maximize the potential of longitudinal data. Results showed that anxiety, sadness and joy share similar trajectories with beliefs and behaviours over the course of therapy. Strengths and limitations of the study are noted. Implications for targeting emotions and thoughts at different stages of therapy are also discussed.

No description available.

Human mesenchymal stem cells (hMSCs) have been identified as a promising cell-based therapy candidate to treat a number of unmet clinical indications, however, in vitro expansion will be required to increase the available number of cells and meet this demand. Scalable manufacturing processes, amenable to closed, single-use and automated technology, must therefore be developed in order to produce safe, effective and affordable hMSC therapies. To address this challenge, a controlled serum-free end-to-end microcarrier process has been developed for hMSCs, which is amenable to large-scale manufacture and therefore increasing economies of scale. Preliminary studies in monolayer culture assessed the level of variability in growth between five hMSC donors, which was found to have a variance of 25.3 % after 30 days in culture. This variance was subsequently reduced to 4.5% by the development of a serum-free monolayer culture process with the maintenance of critical hMSC characteristics and an increased number of population doublings. In order to transfer this into a scalable system, the serum and serum-free expansion processes were transferred into suspension by the addition of plastic microcarriers in 100 mL spinner flasks without control of pH or dissolved oxygen (DO). This achieved a maximum cell density of 0.08 ± 0.01 · 106 cells.mL-1 in FBS-based medium, 0.12 ± 0.01 · 106 cells.mL-1 in HPL-based medium and 0.27 ± 0.03 · 106 cells.mL-1 in serum free medium after six days. In order to drive consistency and yield into the manufacturing process, a process control system was developed for the FBS-based microcarrier expansion process in a 100 mL DASbox bioreactor platform to control DO, pH, impeller rate and temperature. Reduced impeller rates and DO concentrations were found to be beneficial, with a final cell density of 0.11 ± 0.02 · 106 cells.mL-1 and improved post-harvest outgrowth and colony-forming unit (CFU) potential compared to uncontrolled microcarrier and monolayer culture. This controlled bioreactor expansion process was then applied to the previously developed serum-free microcarrier process, eventually achieving a final cell density of 1.04 ± 0.07 · 106 cells.mL-1, whilst retaining key post-harvest hMSC characteristics. Following the controlled serum-free expansion and harvest of hMSCs, a downstream and cryopreservation process was developed to assess the impact of prolonged holding times and subsequent unit-operations on hMSC quality characteristics. This showed that hMSCs are able to maintain key characteristics throughout the entire end-to-end process, demonstrating their potential for commercial scale manufacture.